Skip to content

Validation of the Turkish Version of the S3-NIV Questionnaire

Reliability and Validity of the Turkish Version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation (S3-NIV)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07610122
Enrollment
120
Registered
2026-05-27
Start date
2026-05-21
Completion date
2026-12-30
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Respiratory Failure, Respiratory Insufficiency

Keywords

Non-Invasive Ventilation, Validation, Questionnaire, Reliability, S3-NIV

Brief summary

This study aims to evaluate the psychometric properties, including reliability and validity, of the Turkish version of the Severe Respiratory Insufficiency Questionnaire for Non-Invasive Ventilation (S3-NIV). The S3-NIV is a specific tool designed to assess difficulties and compliance in patients receiving home non-invasive ventilation. A total of 120 stable patients using home NIV for at least 3 months will be enrolled across multiple centers.

Detailed description

Following the official linguistic validation process authorized by the Mapi Research Trust, this multi-center observational study will assess the psychometric validity of the Turkish S3-NIV questionnaire. Patients will complete the 11-item S3-NIV questionnaire alongside a sociodemographic and clinical data form. To evaluate test-retest reliability, a randomly selected subgroup of patients (n=40) will re-complete the questionnaire 14 to 15 days after the initial administration. Internal consistency, construct validity (via factor analysis), and criterion validity (correlations with clinical parameters such as daily NIV usage hours and blood gas values) will be analyzed.

Interventions

OTHERTurkish Version of the S3-NIV Questionnaire

An 11-item self-administered questionnaire designed to evaluate the difficulties and compliance of patients using home non-invasive ventilation (NIV).

Sponsors

Istanbul Saglik Bilimleri University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with chronic respiratory failure requiring home non-invasive ventilation (NIV). * Using a home NIV device for at least 3 months. * Being in a clinically stable phase (no exacerbation or hospitalization in the last 1 month). * Able to understand and answer the questionnaire. * Provided written informed consent.

Exclusion criteria

* Acute respiratory failure or clinical instability. * Severe cognitive impairment or psychiatric disorders preventing reliable communication. * Active malignancy or terminal illness with a short life expectancy. * Refusal to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Internal Consistency and Construct Validity of the Turkish S3-NIVBaseline (Day 0)Evaluated using Cronbach's alpha coefficient for internal consistency and Confirmatory/Exploratory Factor Analysis (CFA/EFA) to confirm the structural validity of the 11-item scale.

Secondary

MeasureTime frameDescription
Test-Retest Reliability14 to 15 days after baselineEvaluated using the Intraclass Correlation Coefficient (ICC) between the first and second administrations of the questionnaire in a randomly selected subgroup.

Countries

Turkey (Türkiye)

Contacts

CONTACTDilek Unsal, PT PhD(c)
fztdlkunsal@gmail.com+90 530 4641198
PRINCIPAL_INVESTIGATORIpek Ozmen, Prof.

Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026